Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abuse, alcohol, alter, avoid, binomial, biosimilar, blanket, Bovet, capacity, CFO, consummation, Darlene, death, dishonesty, employed, Excellence, expiry, extremely, Florida, guarantee, guaranteed, harassment, Head, Horton, instrument, intermittently, Itero, lien, mailing, microbiology, occurrence, omission, Pediatric, penalty, Pink, probabilistic, ratably, real, renegotiate, settled, step, successor, tenure, thePlan, thereto, UF, unadjusted, unrealized, unsuccessfully, Watson, XX
Removed:
attractive, back, carry, collaborate, curtail, deducted, Department, device, encounter, faith, finally, flexibility, forego, harm, hiring, indemnify, intent, investigate, language, losing, moving, negotiated, open, pipeline, prudent, pursuit, qualifying, retention, scale, securing, spend, undergone, violation
Filing tables
Filing exhibits
CAPR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Nile Therapeutics, Inc. on Form S-8 (File No. 333-152283 and 333-175727) and Form S-3 (File No. 333-165167) of our report dated June 21, 2013, relating to the financial statements, appearing in this Annual Report on Form 10-K.
| /s/ Crowe Horwath LLP | |
| New York, New York | |
| June 21, 2013 |